581 related articles for article (PubMed ID: 29106390)
1. Glycolysis gatekeeper PDK1 reprograms breast cancer stem cells under hypoxia.
Peng F; Wang JH; Fan WJ; Meng YT; Li MM; Li TT; Cui B; Wang HF; Zhao Y; An F; Guo T; Liu XF; Zhang L; Lv L; Lv DK; Xu LZ; Xie JJ; Lin WX; Lam EW; Xu J; Liu Q
Oncogene; 2018 Feb; 37(8):1062-1074. PubMed ID: 29106390
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor β upregulated by lncRNA-H19 to promote cancer stem-like properties in papillary thyroid carcinoma.
Li M; Chai HF; Peng F; Meng YT; Zhang LZ; Zhang L; Zou H; Liang QL; Li MM; Mao KG; Sun DX; Tong MY; Deng ZQ; Hou ZJ; Zhao Y; Li J; Wang XC; Lv SS; Zhang QQ; Yu X; Lam EW; Liu Q; Cui XN; Xu J
Cell Death Dis; 2018 Nov; 9(11):1120. PubMed ID: 30389909
[TBL] [Abstract][Full Text] [Related]
3. LncRNA SPRY4-IT1 regulates breast cancer cell stemness through competitively binding miR-6882-3p with TCF7L2.
Song X; Zhang X; Wang X; Chen L; Jiang L; Zheng A; Zhang M; Zhao L; Wei M
J Cell Mol Med; 2020 Jan; 24(1):772-784. PubMed ID: 31736268
[TBL] [Abstract][Full Text] [Related]
4. H19/let-7/LIN28 reciprocal negative regulatory circuit promotes breast cancer stem cell maintenance.
Peng F; Li TT; Wang KL; Xiao GQ; Wang JH; Zhao HD; Kang ZJ; Fan WJ; Zhu LL; Li M; Cui B; Zheng FM; Wang HJ; Lam EW; Wang B; Xu J; Liu Q
Cell Death Dis; 2017 Jan; 8(1):e2569. PubMed ID: 28102845
[TBL] [Abstract][Full Text] [Related]
5. Hypoxic Glioma Stem Cell-Derived Exosomes Containing Linc01060 Promote Progression of Glioma by Regulating the MZF1/c-Myc/HIF1α Axis.
Li J; Liao T; Liu H; Yuan H; Ouyang T; Wang J; Chai S; Li J; Chen J; Li X; Zhao H; Xiong N
Cancer Res; 2021 Jan; 81(1):114-128. PubMed ID: 33158815
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia promotes the phenotypic change of aldehyde dehydrogenase activity of breast cancer stem cells.
Shiraishi A; Tachi K; Essid N; Tsuboi I; Nagano M; Kato T; Yamashita T; Bando H; Hara H; Ohneda O
Cancer Sci; 2017 Mar; 108(3):362-372. PubMed ID: 28012234
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of CXCR7 inhibits proliferative capacity and stem cell-like properties in breast cancer stem cells.
Tang X; Li X; Li Z; Liu Y; Yao L; Song S; Yang H; Li C
Tumour Biol; 2016 Oct; 37(10):13425-13433. PubMed ID: 27460092
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA SOX2OT promotes the stemness phenotype of bladder cancer cells by modulating SOX2.
Zhan Y; Chen Z; He S; Gong Y; He A; Li Y; Zhang L; Zhang X; Fang D; Li X; Zhou L
Mol Cancer; 2020 Feb; 19(1):25. PubMed ID: 32019566
[TBL] [Abstract][Full Text] [Related]
9. EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells.
Dillard C; Kiyohara M; Mah V; McDermott SP; Bazzoun D; Tsui J; Chan AM; Haddad G; Pellegrini M; Chang YL; Elshimali Y; Wu Y; Vadgama JV; Kim SR; Goodglick L; Law SM; Patel DD; Dhawan P; O'Brien NA; Gordon LK; Braun J; Lazar G; Wicha MS; Wadehra M
Mol Cancer Ther; 2020 Aug; 19(8):1682-1695. PubMed ID: 32451329
[TBL] [Abstract][Full Text] [Related]
10. Lin28/let-7 axis regulates aerobic glycolysis and cancer progression via PDK1.
Ma X; Li C; Sun L; Huang D; Li T; He X; Wu G; Yang Z; Zhong X; Song L; Gao P; Zhang H
Nat Commun; 2014 Oct; 5():5212. PubMed ID: 25301052
[TBL] [Abstract][Full Text] [Related]
11. PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer.
Dupuy F; Tabariès S; Andrzejewski S; Dong Z; Blagih J; Annis MG; Omeroglu A; Gao D; Leung S; Amir E; Clemons M; Aguilar-Mahecha A; Basik M; Vincent EE; St-Pierre J; Jones RG; Siegel PM
Cell Metab; 2015 Oct; 22(4):577-89. PubMed ID: 26365179
[TBL] [Abstract][Full Text] [Related]
12. HIF1α modulates cell fate reprogramming through early glycolytic shift and upregulation of PDK1-3 and PKM2.
Prigione A; Rohwer N; Hoffmann S; Mlody B; Drews K; Bukowiecki R; Blümlein K; Wanker EE; Ralser M; Cramer T; Adjaye J
Stem Cells; 2014 Feb; 32(2):364-76. PubMed ID: 24123565
[TBL] [Abstract][Full Text] [Related]
13. The double inhibition of PDK1 and STAT3-Y705 prevents liver metastasis in colorectal cancer.
Qin W; Tian Y; Zhang J; Liu W; Zhou Q; Hu S; Yang F; Lu L; Lu H; Cui S; Wen L; Wei S
Sci Rep; 2019 Sep; 9(1):12973. PubMed ID: 31506552
[TBL] [Abstract][Full Text] [Related]
14. MiR-7 reduces the BCSC subset by inhibiting XIST to modulate the miR-92b/Slug/ESA axis and inhibit tumor growth.
Li M; Pan M; You C; Zhao F; Wu D; Guo M; Xu H; Shi F; Zheng D; Dou J
Breast Cancer Res; 2020 Mar; 22(1):26. PubMed ID: 32143670
[TBL] [Abstract][Full Text] [Related]
15. SETD5 Regulates Glycolysis in Breast Cancer Stem-Like Cells and Fuels Tumor Growth.
Yang Z; Zhang C; Liu X; Che N; Feng Y; Xuan Y
Am J Pathol; 2022 Apr; 192(4):712-721. PubMed ID: 35063407
[TBL] [Abstract][Full Text] [Related]
16. lncRNA nuclear-enriched abundant transcript 1 promotes cell proliferation and invasion by targeting miR-186-5p/HIF-1α in osteosarcoma.
Tan H; Zhao L
J Cell Biochem; 2019 Apr; 120(4):6502-6514. PubMed ID: 30485482
[TBL] [Abstract][Full Text] [Related]
17. SIRT3 elicited an anti-Warburg effect through HIF1α/PDK1/PDHA1 to inhibit cholangiocarcinoma tumorigenesis.
Xu L; Li Y; Zhou L; Dorfman RG; Liu L; Cai R; Jiang C; Tang D; Wang Y; Zou X; Wang L; Zhang M
Cancer Med; 2019 May; 8(5):2380-2391. PubMed ID: 30993888
[TBL] [Abstract][Full Text] [Related]
18. The HIF-1α antisense long non-coding RNA drives a positive feedback loop of HIF-1α mediated transactivation and glycolysis.
Zheng F; Chen J; Zhang X; Wang Z; Chen J; Lin X; Huang H; Fu W; Liang J; Wu W; Li B; Yao H; Hu H; Song E
Nat Commun; 2021 Feb; 12(1):1341. PubMed ID: 33637716
[TBL] [Abstract][Full Text] [Related]
19. Lnc RNA H19 is associated with poor prognosis in breast cancer patients and promotes cancer stemness.
Shima H; Kida K; Adachi S; Yamada A; Sugae S; Narui K; Miyagi Y; Nishi M; Ryo A; Murata S; Taniguchi H; Ichikawa Y; Ishikawa T; Endo I
Breast Cancer Res Treat; 2018 Aug; 170(3):507-516. PubMed ID: 29693231
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA LUCAT1/miR-5582-3p/TCF7L2 axis regulates breast cancer stemness via Wnt/β-catenin pathway.
Zheng A; Song X; Zhang L; Zhao L; Mao X; Wei M; Jin F
J Exp Clin Cancer Res; 2019 Jul; 38(1):305. PubMed ID: 31300015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
